
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $3.5B | $4.1B | $4.5B | $4.8B | $4.6B | |
Revenue Growth (YoY) | -7.3% | 17.64% | 8.8% | 6.06% | -4.11% | |
Cost of Revenues | $2.5B | $3B | $3.2B | $3.3B | $3.1B | |
Gross Profit | $1B | $1.1B | $1.3B | $1.5B | $1.4B | |
Gross Profit Margin | 28.75% | 27.81% | 29.62% | 31.64% | 31.51% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $533.8M | $580.5M | $637.1M | $740.8M | $752M | |
Other Inc / (Exp) | -$15.9M | $11.1M | -$29.3M | -$70.7M | -$6.3M | |
Operating Expenses | $533.8M | $627.3M | $681M | $806.5M | $830M | |
Operating Income | $476.1M | $522M | $651M | $702.6M | $610.7M | |
Net Interest Expenses | $63.9M | $56.5M | $70.8M | $101.4M | $110.2M | |
EBT. Incl. Unusual Items | $396.3M | $476.6M | $550.9M | $530.5M | $494.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $103.9M | $95.1M | $133.9M | $122.5M | $118.9M | |
Net Income to Company | $292.4M | $381.5M | $417M | $408M | $375.3M | |
Minority Interest in Earnings | -$7.9M | -$12.4M | -$9.6M | -$13.9M | -$22.6M | |
Net Income to Common Excl Extra Items | $284.5M | $369.1M | $407.4M | $394.1M | $352.7M | |
Basic EPS (Cont. Ops) | $3.78 | $4.86 | $5.54 | $5.52 | $5.02 | |
Diluted EPS (Cont. Ops) | $3.72 | $4.79 | $5.48 | $5.47 | $4.99 | |
Weighted Average Basic Share | $75.4M | $75.9M | $73.6M | $71.4M | $70.2M | |
Weighted Average Diluted Share | $76.4M | $77M | $74.3M | $72.1M | $70.8M | |
EBITDA | $631M | $703.2M | $789.5M | $842.5M | $841.1M | |
EBIT | $463.9M | $535.4M | $625.5M | $641.2M | $619.3M | |
Revenue (Reported) | $3.5B | $4.1B | $4.5B | $4.8B | $4.6B | |
Operating Income (Reported) | $476.1M | $522M | $651M | $702.6M | $610.7M | |
Operating Income (Adjusted) | $463.9M | $535.4M | $625.5M | $641.2M | $619.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1B | $1.1B | $1.3B | $1.2B | $1.1B | |
Revenue Growth (YoY) | 11.05% | 9.67% | 12.29% | -5.74% | -4.2% | |
Cost of Revenues | $726.2M | $786.3M | $846M | $792.7M | $781.6M | |
Gross Profit | $299.2M | $338.3M | $416.8M | $397.6M | $358.7M | |
Gross Profit Margin | 29.18% | 30.08% | 33.01% | 33.4% | 31.46% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $144.5M | $154.1M | $186.8M | $190.7M | $184.8M | |
Other Inc / (Exp) | $1M | $500K | -$25.7M | -$4.2M | -$12.4M | |
Operating Expenses | $144.5M | $165M | $200.3M | $210.7M | $203.8M | |
Operating Income | $154.7M | $173.3M | $216.5M | $186.9M | $154.9M | |
Net Interest Expenses | $14.4M | $13.7M | $22.6M | $29.4M | $24.2M | |
EBT. Incl. Unusual Items | $141.3M | $160.1M | $168.2M | $153.3M | $118.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $25.3M | $38.2M | $42.5M | $42.7M | $26.9M | |
Net Income to Company | $116M | $121.9M | $125.7M | $110.6M | $91.4M | |
Minority Interest in Earnings | -$2.7M | -$3.7M | -$3.4M | -$7.1M | -$13.1M | |
Net Income to Common Excl Extra Items | $113.3M | $118.2M | $122.3M | $103.5M | $78.3M | |
Basic EPS (Cont. Ops) | $1.49 | $1.58 | $1.69 | $1.47 | $1.12 | |
Diluted EPS (Cont. Ops) | $1.47 | $1.56 | $1.67 | $1.46 | $1.11 | |
Weighted Average Basic Share | $75.8M | $74.8M | $72.5M | $70.3M | $70M | |
Weighted Average Diluted Share | $77.3M | $75.5M | $73.4M | $70.9M | $70.5M | |
EBITDA | $199.2M | $215.8M | $237.9M | $240.8M | $199.9M | |
EBIT | $156.2M | $174.4M | $192.3M | $185.5M | $144.8M | |
Revenue (Reported) | $1B | $1.1B | $1.3B | $1.2B | $1.1B | |
Operating Income (Reported) | $154.7M | $173.3M | $216.5M | $186.9M | $154.9M | |
Operating Income (Adjusted) | $156.2M | $174.4M | $192.3M | $185.5M | $144.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.6B | $4.2B | $4.6B | $4.7B | $4.5B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.6B | $3B | $3.2B | $3.2B | $3.1B | |
Gross Profit | $1B | $1.2B | $1.4B | $1.5B | $1.4B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $524.7M | $590.1M | $669.8M | $744.7M | $746.1M | |
Other Inc / (Exp) | -$19M | $10.6M | -$55.5M | -$49.2M | -$14.5M | |
Operating Expenses | $524.7M | $647.8M | $716.3M | $816.9M | $823.1M | |
Operating Income | $505.5M | $540.6M | $694.2M | $673M | $578.7M | |
Net Interest Expenses | $62.7M | $55.8M | $79.7M | $108.2M | $105M | |
EBT. Incl. Unusual Items | $424M | $495.4M | $559M | $515.6M | $459.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $99.6M | $108M | $138.2M | $122.7M | $103.1M | |
Net Income to Company | $324.4M | $387.4M | $420.8M | $392.9M | $356.1M | |
Minority Interest in Earnings | -$7.3M | -$13.4M | -$9.3M | -$17.6M | -$28.6M | |
Net Income to Common Excl Extra Items | $317.1M | $374M | $411.5M | $375.3M | $327.5M | |
Basic EPS (Cont. Ops) | $4.19 | $4.95 | $5.65 | $5.29 | $4.68 | |
Diluted EPS (Cont. Ops) | $4.14 | $4.88 | $5.59 | $5.25 | $4.64 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $657.2M | $719.8M | $811.6M | $845.4M | $800.2M | |
EBIT | $489.4M | $553.6M | $643.4M | $634.4M | $578.6M | |
Revenue (Reported) | $3.6B | $4.2B | $4.6B | $4.7B | $4.5B | |
Operating Income (Reported) | $505.5M | $540.6M | $694.2M | $673M | $578.7M | |
Operating Income (Adjusted) | $489.4M | $553.6M | $643.4M | $634.4M | $578.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1B | $1.1B | $1.3B | $1.2B | $1.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $726.2M | $786.3M | $846M | $792.7M | $781.6M | |
Gross Profit | $299.2M | $338.3M | $416.8M | $397.6M | $358.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $144.5M | $154.1M | $186.8M | $190.7M | $184.8M | |
Other Inc / (Exp) | $1M | $500K | -$25.7M | -$4.2M | -$12.4M | |
Operating Expenses | $144.5M | $165M | $200.3M | $210.7M | $203.8M | |
Operating Income | $154.7M | $173.3M | $216.5M | $186.9M | $154.9M | |
Net Interest Expenses | $14.4M | $13.7M | $22.6M | $29.4M | $24.2M | |
EBT. Incl. Unusual Items | $141.3M | $160.1M | $168.2M | $153.3M | $118.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $25.3M | $38.2M | $42.5M | $42.7M | $26.9M | |
Net Income to Company | $116M | $121.9M | $125.7M | $110.6M | $91.4M | |
Minority Interest in Earnings | -$2.7M | -$3.7M | -$3.4M | -$7.1M | -$13.1M | |
Net Income to Common Excl Extra Items | $113.3M | $118.2M | $122.3M | $103.5M | $78.3M | |
Basic EPS (Cont. Ops) | $1.49 | $1.58 | $1.69 | $1.47 | $1.12 | |
Diluted EPS (Cont. Ops) | $1.47 | $1.56 | $1.67 | $1.46 | $1.11 | |
Weighted Average Basic Share | $75.8M | $74.8M | $72.5M | $70.3M | $70M | |
Weighted Average Diluted Share | $77.3M | $75.5M | $73.4M | $70.9M | $70.5M | |
EBITDA | $199.2M | $215.8M | $237.9M | $240.8M | $199.9M | |
EBIT | $156.2M | $174.4M | $192.3M | $185.5M | $144.8M | |
Revenue (Reported) | $1B | $1.1B | $1.3B | $1.2B | $1.1B | |
Operating Income (Reported) | $154.7M | $173.3M | $216.5M | $186.9M | $154.9M | |
Operating Income (Adjusted) | $156.2M | $174.4M | $192.3M | $185.5M | $144.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $320.3M | $257.1M | $331.6M | $418.9M | $373.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $581.1M | $626.4M | $699.6M | $671.7M | $664.6M | |
Inventory | $841.3M | $1B | $1.2B | $1.2B | $1.2B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $106M | $149.8M | $124.1M | $128.8M | $102.8M | |
Total Current Assets | $2B | $2.2B | $2.5B | $2.6B | $2.5B | |
Property Plant And Equipment | $1.2B | $1.2B | $1.3B | $1.4B | $1.4B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1B | $1B | $1.1B | $1.4B | $1.4B | |
Other Intangibles | $741.4M | $668.8M | $765.3M | $1B | $1B | |
Other Long-Term Assets | $21.5M | $23.9M | $25M | $29.9M | $25.8M | |
Total Assets | $5B | $5.2B | $5.8B | $6.5B | $6.4B | |
Accounts Payable | $351.4M | $430M | $403.9M | $367.2M | $321.7M | |
Accrued Expenses | $146.5M | $146.8M | $170.3M | $177.9M | $167.5M | |
Current Portion Of Long-Term Debt | $10.9M | $53.8M | $49M | $605.6M | $13M | |
Current Portion Of Capital Lease Obligations | $27.2M | $26.2M | $24.1M | $25.9M | $32M | |
Other Current Liabilities | $152.4M | $186.8M | $237.7M | $205.8M | $191M | |
Total Current Liabilities | $848M | $896.6M | $1B | $1.5B | $820.5M | |
Long-Term Debt | $1.4B | $1.4B | $1.9B | $1.8B | $2B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.8B | $2.8B | $3.4B | $3.8B | $3.4B | |
Common Stock | $40.7M | $40.7M | $40.7M | $40.7M | $40.7M | |
Other Common Equity Adj | $41.3M | -$23M | -$181.9M | -$146.9M | -$301.7M | |
Common Equity | $2.2B | $2.3B | $2.3B | $2.6B | $2.8B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $72.3M | $82.8M | $84.6M | $120M | $157.6M | |
Total Equity | $2.2B | $2.4B | $2.4B | $2.7B | $3B | |
Total Liabilities and Equity | $5B | $5.2B | $5.8B | $6.5B | $6.4B | |
Cash and Short Terms | $320.3M | $257.1M | $331.6M | $418.9M | $373.2M | |
Total Debt | $1.6B | $1.5B | $2B | $2.4B | $2.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $302.3M | $424.5M | $330.5M | $421.9M | $376.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $712.3M | $743.9M | $758.1M | $770.4M | $744.6M | |
Inventory | $864.8M | $1.1B | $1.2B | $1.2B | $1.2B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $109.8M | $137.1M | $122.8M | $90.2M | $89.5M | |
Total Current Assets | $2.1B | $2.5B | $2.6B | $2.7B | $2.6B | |
Property Plant And Equipment | $1.1B | $1.2B | $1.3B | $1.4B | $1.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1B | $1B | $1.1B | $1.4B | $1.4B | |
Other Intangibles | $712.6M | $648.6M | $755.3M | $990.1M | $1B | |
Other Long-Term Assets | $18M | $29.4M | $25.7M | $28.9M | $29M | |
Total Assets | $5.1B | $5.5B | $5.9B | $6.5B | $6.6B | |
Accounts Payable | $362.6M | $416.1M | $390.5M | $373M | $338.5M | |
Accrued Expenses | $120.2M | $126.6M | $148.8M | $151.5M | $163.3M | |
Current Portion Of Long-Term Debt | $10.8M | $11.1M | $48.6M | $601.9M | $21.7M | |
Current Portion Of Capital Lease Obligations | $26.2M | $25.7M | $25.3M | $25.8M | $32.4M | |
Other Current Liabilities | $204.6M | $198.3M | $199.7M | $186.2M | $169.2M | |
Total Current Liabilities | $916.8M | $866.2M | $940M | $1.4B | $831.7M | |
Long-Term Debt | $1.4B | $1.7B | $2B | $1.8B | $2.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.9B | $3.1B | $3.4B | $3.8B | $3.5B | |
Common Stock | $40.7M | $40.7M | $40.7M | $40.7M | $40.7M | |
Other Common Equity Adj | -$2.1M | -$42.5M | -$156.8M | -$197.6M | -$238.9M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $74.6M | $83.9M | $88.3M | $126.7M | $171.3M | |
Total Equity | $2.3B | $2.4B | $2.4B | $2.7B | $3.1B | |
Total Liabilities and Equity | $5.1B | $5.5B | $5.9B | $6.5B | $6.6B | |
Cash and Short Terms | $302.3M | $424.5M | $330.5M | $421.9M | $376.1M | |
Total Debt | $1.6B | $1.8B | $2B | $2.4B | $2.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $292.4M | $381.5M | $417M | $408M | $375.3M | |
Depreciation & Amoritzation | $167.1M | $167.8M | $164M | $201.3M | $221.8M | |
Stock-Based Compensation | $23.2M | $20.2M | $30.4M | $30.6M | $25.9M | |
Change in Accounts Receivable | -$2.2M | -$49.6M | -$99.5M | $31.2M | -$10.9M | |
Change in Inventories | $27.4M | -$215.8M | -$145.6M | $72M | $9.6M | |
Cash From Operations | $577.6M | $387.3M | $463.8M | $545.2M | $475.7M | |
Capital Expenditures | $121.6M | $148.3M | $178.4M | $187.8M | $170M | |
Cash Acquisitions | -$24M | -$7.5M | -$419.8M | -$625.3M | -$167.1M | |
Cash From Investing | -$153.5M | -$173.8M | -$573.3M | -$806.5M | -$304.6M | |
Dividends Paid (Ex Special Dividend) | -$87M | -$92.2M | -$91.7M | -$94M | -$96.1M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $706M | $635.9M | $1.7B | $1.7B | $2.2B | |
Long-Term Debt Repaid | -$943.7M | -$707.2M | -$1.2B | -$1.5B | -$2.3B | |
Repurchase of Common Stock | -$49.3M | -$93M | -$211.6M | -$250.9M | -$40.5M | |
Other Financing Activities | -$34.6M | -$24.3M | -$11.3M | -$22.5M | -$17.8M | |
Cash From Financing | -$331.1M | -$269.3M | $206.8M | $347.1M | -$194.8M | |
Beginning Cash (CF) | $216.2M | $321.1M | $257.9M | $340.7M | $419.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $93M | -$55.8M | $97.3M | $85.8M | -$23.7M | |
Ending Cash (CF) | $321.1M | $257.9M | $340.7M | $419.3M | $373.6M | |
Levered Free Cash Flow | $456M | $239M | $285.4M | $357.4M | $305.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $116M | $121.9M | $125.7M | $110.6M | $91.4M | |
Depreciation & Amoritzation | $43M | $41.4M | $45.6M | $55.3M | $55.1M | |
Stock-Based Compensation | $6.5M | $7.1M | $11M | $4.5M | $7.5M | |
Change in Accounts Receivable | -$141.4M | -$102.1M | -$61.4M | -$96.6M | -$89M | |
Change in Inventories | -$33.3M | -$70.2M | $6.1M | -$11.1M | $15.3M | |
Cash From Operations | $31.7M | -$1.2M | $78.6M | $49.3M | $58.6M | |
Capital Expenditures | $29.4M | $34.3M | $41.7M | $44.1M | $35.2M | |
Cash Acquisitions | -- | -- | -$23.5M | -- | -- | |
Cash From Investing | -$39.4M | -$35M | -$64.5M | -$24.5M | -$32.5M | |
Dividends Paid (Ex Special Dividend) | -$23.8M | -$23.5M | -$23.6M | -$24.5M | -$25.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $136.1M | $624.3M | $166M | $233.3M | $57M | |
Long-Term Debt Repaid | -$97.5M | -$282.7M | -$96.7M | -$218.9M | -$28.2M | |
Repurchase of Common Stock | -$26.3M | -$100M | -$54M | -- | -$23.1M | |
Other Financing Activities | -$17.8M | -$3.7M | -$13.8M | -$8.9M | -$9.5M | |
Cash From Financing | -$6.4M | $204.7M | -$17.5M | -$15M | -$30.6M | |
Beginning Cash (CF) | $321.1M | $257.9M | $340.7M | $419.3M | $373.6M | |
Foreign Exchange Rate Adjustment | -$3.9M | -$1.2M | $1.8M | -$6.8M | $7.4M | |
Additions / Reductions | -$14.1M | $168.5M | -$3.4M | $9.8M | -$4.5M | |
Ending Cash (CF) | $303.1M | $425.2M | $339.1M | $422.3M | $376.5M | |
Levered Free Cash Flow | $2.3M | -$35.5M | $36.9M | $5.2M | $23.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $324.4M | $387.4M | $420.8M | $392.9M | $356.1M | |
Depreciation & Amoritzation | $167.8M | $166.2M | $168.2M | $211M | $221.6M | |
Stock-Based Compensation | $24.1M | $20.8M | $34.3M | $24.1M | $28.9M | |
Change in Accounts Receivable | -$87.7M | -$10.3M | -$58.8M | -$4M | -$3.3M | |
Change in Inventories | -$6.2M | -$252.7M | -$69.3M | $54.8M | $36M | |
Cash From Operations | $553.1M | $354.4M | $543.6M | $515.9M | $485M | |
Capital Expenditures | $119.2M | $153.2M | $185.8M | $190.2M | $161.1M | |
Cash Acquisitions | -$24M | -$7.5M | -$443.3M | -$601.8M | -$167.1M | |
Cash From Investing | -$161.3M | -$169.4M | -$602.8M | -$766.5M | -$312.6M | |
Dividends Paid (Ex Special Dividend) | -$87.9M | -$91.9M | -$91.8M | -$94.9M | -$96.7M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $559.8M | $1.1B | $1.2B | $1.7B | $2B | |
Long-Term Debt Repaid | -$993.3M | -$892.4M | -$1B | -$1.6B | -$2.1B | |
Repurchase of Common Stock | -$33.3M | -$166.7M | -$165.6M | -$196.9M | -$63.6M | |
Other Financing Activities | -$42.2M | -$10.2M | -$21.4M | -$17.6M | -$18.4M | |
Cash From Financing | -$504M | -$58.2M | -$15.4M | $349.6M | -$210.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$112.2M | $126.8M | -$74.6M | $99M | -$38M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $433.9M | $201.2M | $357.8M | $325.7M | $323.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $116M | $121.9M | $125.7M | $110.6M | $91.4M | |
Depreciation & Amoritzation | $43M | $41.4M | $45.6M | $55.3M | $55.1M | |
Stock-Based Compensation | $6.5M | $7.1M | $11M | $4.5M | $7.5M | |
Change in Accounts Receivable | -$141.4M | -$102.1M | -$61.4M | -$96.6M | -$89M | |
Change in Inventories | -$33.3M | -$70.2M | $6.1M | -$11.1M | $15.3M | |
Cash From Operations | $31.7M | -$1.2M | $78.6M | $49.3M | $58.6M | |
Capital Expenditures | $29.4M | $34.3M | $41.7M | $44.1M | $35.2M | |
Cash Acquisitions | -- | -- | -$23.5M | -- | -- | |
Cash From Investing | -$39.4M | -$35M | -$64.5M | -$24.5M | -$32.5M | |
Dividends Paid (Ex Special Dividend) | -$23.8M | -$23.5M | -$23.6M | -$24.5M | -$25.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $136.1M | $624.3M | $166M | $233.3M | $57M | |
Long-Term Debt Repaid | -$97.5M | -$282.7M | -$96.7M | -$218.9M | -$28.2M | |
Repurchase of Common Stock | -$26.3M | -$100M | -$54M | -- | -$23.1M | |
Other Financing Activities | -$17.8M | -$3.7M | -$13.8M | -$8.9M | -$9.5M | |
Cash From Financing | -$6.4M | $204.7M | -$17.5M | -$15M | -$30.6M | |
Beginning Cash (CF) | $321.1M | $257.9M | $340.7M | $419.3M | $373.6M | |
Foreign Exchange Rate Adjustment | -$3.9M | -$1.2M | $1.8M | -$6.8M | $7.4M | |
Additions / Reductions | -$14.1M | $168.5M | -$3.4M | $9.8M | -$4.5M | |
Ending Cash (CF) | $303.1M | $425.2M | $339.1M | $422.3M | $376.5M | |
Levered Free Cash Flow | $2.3M | -$35.5M | $36.9M | $5.2M | $23.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.